Article
<i>In vivo</i> generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearance
2025-04-24
Abstract excerpt
Despite striking efficacy against hematologic malignancies, the cost and complexity of CAR T manufacturing present significant barriers to broader patient access. Beyond manufacturing challenges, ex vivo expansion of T cells may be detrimental for their function and persistence. Thus, delivery of CARs to reprogram host cells in vivo would represent a significant advance toward “off-the-shelf” therapy but has bee...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c1e9c81e-73e8-5f22-a3c6-fe23296f5aeb
- DOI
- 10.1101/2025.04.23.645810
